Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Income Statement 2011–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenue | 510.2M | 426.5M | 258.2M | 154.1M | 80.9M | 42.2M | 29.3M | 17.0M | 22.8M | 10.7M | 7.2M | 5.9M | 3.1M | 1.1M | 761,042 |
| Gross Profit | 292.8M | 219.6M | 88.9M | 35.3M | 1.2M | -19.1M | -10.2M | -25.2M | -6.4M | 4.3M | 2.9M | 2.2M | 1.0M | 449,062 | 553,472 |
| Profitability | |||||||||||||||
| Operating Income | 191.4M | 139.0M | 21.6M | -39.4M | -58.4M | -64.9M | -41.4M | -60.3M | -39.3M | -17.3M | -15.5M | -16.0M | -15.0M | -7.9M | -4.6M |
| EBITDA | 199.4M | 146.7M | 29.2M | -33.0M | -53.6M | -61.7M | -39.0M | -57.7M | -37.8M | -16.9M | -15.0M | -15.8M | -14.8M | -7.7M | -4.4M |
| Net Income | 146.9M | 197.7M | -28.2M | -65.9M | -71.6M | -75.7M | -48.3M | -65.7M | -43.8M | -19.5M | -18.0M | -16.8M | -15.5M | -7.3M | -5.9M |
| Per Share Data | |||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 245M | 243M | 224M | 198M | 140M | 86M | 59M | 46M | 37M | 13M | 11M | 9M | 9M | 6M | 0M |
Adma Biologics Inc. Income Statement — FAQ
Adma Biologics Inc. (ADMA) income statement over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's income statement history?
The chart and table above show Adma Biologics Inc.'s income statement by year and by quarter, including the growth rate.